Dexchlorpheniramine Maleate


Indications and Reactions:

Role Indications Reactions
Secondary
Premedication 23.8%
Product Used For Unknown Indication 22.5%
Drug Use For Unknown Indication 10.6%
Conjunctivitis Allergic 5.3%
Tongue Neoplasm Malignant Stage Unspecified 5.3%
Breast Cancer 4.6%
Urticaria 3.3%
Extragonadal Primary Germ Cell Tumour Mixed Stage I 2.6%
Pain 2.6%
Rectal Cancer 2.6%
Renal Transplant 2.6%
Hypopharyngeal Cancer 2.0%
Nausea 2.0%
Pruritus 2.0%
Acute Promyelocytic Leukaemia 1.3%
Ankylosing Spondylitis 1.3%
Breast Neoplasm 1.3%
Chemotherapy 1.3%
Epilepsy 1.3%
Extragonadal Primary Germ Cell Cancer 1.3%
Urticaria 11.4%
Drug Hypersensitivity 8.6%
Malaise 8.6%
Febrile Bone Marrow Aplasia 5.7%
Hepatitis Cholestatic 5.7%
Pruritus 5.7%
Rash 5.7%
Rash Erythematous 5.7%
Somnolence 5.7%
Tachycardia 5.7%
Type Iii Immune Complex Mediated Reaction 5.7%
Acute Hepatic Failure 2.9%
Anaemia 2.9%
Anaphylactic Shock 2.9%
Drug Interaction 2.9%
Erythema 2.9%
Hypotension 2.9%
Ileitis 2.9%
Infection 2.9%
Interstitial Lung Disease 2.9%
Concomitant
Product Used For Unknown Indication 17.4%
Prophylaxis 14.8%
Premedication 11.6%
Aplastic Anaemia 9.2%
Drug Use For Unknown Indication 6.9%
Infection Prophylaxis 6.3%
Bone Marrow Conditioning Regimen 5.7%
Hiv Infection 4.5%
Behcet's Syndrome 3.3%
Hypertension 3.0%
Prophylaxis Against Graft Versus Host Disease 3.0%
Antiviral Prophylaxis 2.1%
Antifungal Prophylaxis 1.8%
Nodular (Follicular) Lymphoma 1.8%
Prophylaxis Of Nausea And Vomiting 1.6%
Crohn's Disease 1.5%
Psoriasis 1.4%
Sinusitis 1.4%
Prophylaxis Against Gastrointestinal Ulcer 1.3%
Gastritis Prophylaxis 1.2%
White Blood Cell Count Decreased 13.5%
Small Intestinal Obstruction 9.6%
Vomiting 7.7%
Pyrexia 6.7%
Venoocclusive Liver Disease 5.8%
Obsessive-compulsive Disorder 4.8%
Pseudomembranous Colitis 4.8%
Therapeutic Response Decreased 4.8%
Urinary Tract Infection 4.8%
Weight Increased 4.8%
Hemiplegia 3.8%
Infusion Related Reaction 3.8%
Pneumonia 3.8%
Transaminases Increased 3.8%
Cytolytic Hepatitis 2.9%
Gastroenteritis 2.9%
Herpes Zoster 2.9%
Hyperglycaemia 2.9%
Liver Injury 2.9%
Palmar-plantar Erythrodysaesthesia Syndrome 2.9%

Drug Data